GO:2000136 regulation of cell proliferation involved in heart morphogenesis: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000136 describes any process that modulates the frequency, rate or extent of cell proliferation specifically during heart morphogenesis.
• It sits at the intersection of cardiac development and regenerative biology, controlling how many cardiomyocytes, fibroblasts and endothelial cells are produced as the heart is built.
• Key signaling inputs include EGF receptor, FGF, Notch and TGF-beta pathways, which converge on cell-cycle regulators in the developing myocardium.
• Zebrafish heart regeneration depends on cardiomyocyte dedifferentiation and proliferation, making it a powerful model for this GO term.
• Dysregulation of proliferation during heart morphogenesis contributes to congenital heart defects and adverse cardiac remodeling.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of candidate regulators in this process.
Description
GO:2000136, regulation of cell proliferation involved in heart morphogenesis, is a biological process term that captures the control layer governing how many cells are produced while the heart is being built. It is not simply cell proliferation; it is the modulation of proliferation specifically in the context of heart morphogenesis, meaning the signals, transcription factors and cell-cycle machinery that tune proliferative output during cardiac development. Because the heart is one of the first organs to form and must function continuously, the number and identity of its cells must be tightly regulated; too few cells produce a hypoplastic heart, while inappropriate proliferation can disrupt chamber architecture. Researchers study this term to understand congenital heart disease, cardiac regeneration and the signaling logic that couples developmental morphogenesis to cell-cycle control. The process is conserved across vertebrates, and much of what is known comes from zebrafish, mouse and cell-culture models in which EGF receptor, FGF, Notch and TGF-beta signaling have been manipulated. In this article we define GO:2000136, outline its molecular and cellular mechanisms, list the genes most often implicated, and describe how CRISPR-based models and modern profiling methods are used to interrogate it.
regulation of cell proliferation involved in heart morphogenesis At A Glance
| GO ID | GO:2000136 |
|---|---|
| GO term | regulation of cell proliferation involved in heart morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of cell proliferation during heart morphogenesis |
| Process context | Cardiac development and morphogenesis |
| Key signaling inputs | EGF receptor, FGF, Notch, TGF-beta pathways |
| Representative models | Zebrafish, mouse, cardiac cell culture |
| Disease relevance | Congenital heart defects, cardiac remodeling |
What Is GO:2000136?
According to the QuickGO definition, GO:2000136 is any process that modulates the frequency, rate or extent of cell proliferation involved in heart morphogenesis. In practical terms, it is the regulatory arm of cardiac cell proliferation: it includes the extracellular signals, receptors, intracellular cascades and transcription factors that adjust how often cardiac progenitor cells, cardiomyocytes, fibroblasts and endothelial cells divide during heart formation. It does not describe the mechanics of mitosis itself, but rather the control of when, where and how much proliferation occurs as the heart acquires its shape and cell composition.
Why Is regulation of cell proliferation involved in heart morphogenesis Important in Cell Biology?
GO:2000136 matters because the heart must achieve a precise cell number and arrangement during development, and the regulatory inputs that control proliferation are also reactivated or dysregulated in disease. EGF receptor signaling is a central regulator of organ development and tissue homeostasis, and its manipulation alters proliferative behavior in developing tissues. FGF-dependent metabolic control influences vascular development, linking proliferation to metabolic state in the forming heart. In the adult heart, fibroblast activation and Notch/TGF-beta signaling drive remodeling, showing that developmental proliferation control pathways can be co-opted in pathology. Zebrafish can regenerate heart muscle through cardiomyocyte dedifferentiation and proliferation, demonstrating that the proliferative programs controlled by this GO term can be reactivated. Understanding GO:2000136 therefore informs congenital heart disease mechanisms, regenerative medicine strategies and the interpretation of cardiac cell models.
• Defines the regulatory layer that sets cardiomyocyte and non-myocyte numbers during heart formation.
• Connects developmental signaling (EGF, FGF, Notch, TGF-beta) to cell-cycle control in the heart.
• Provides a framework for understanding congenital heart defects caused by altered proliferation.
• Explains why zebrafish can regenerate heart muscle by reactivating cardiomyocyte proliferation.
• Links cardiac fibroblast behavior to Notch and TGF-beta signaling in remodeling.
• Supports identification of therapeutic targets for cardiac repair and regeneration.
• Guides interpretation of single-cell and lineage-tracing data in cardiac development.
• Enables causal testing of candidate regulators using CRISPR knockout and knock-in models.
• Connects metabolic and vascular signals to proliferative control in the developing heart.
• Provides a GO annotation target for functional enrichment in cardiac developmental studies.
What Happens During regulation of cell proliferation involved in heart morphogenesis?
Initiation by extracellular signals
In simple terms: The process starts when growth factors tell heart cells to divide.
Regulation of cell proliferation involved in heart morphogenesis begins with extracellular cues that act on cardiac cells. EGF receptor signaling is a well-established regulator of organ development and tissue homeostasis, and it can promote or restrict proliferative expansion depending on context. FGF signaling provides metabolic and proliferative inputs that are especially important for vascular development within the forming heart. These signals are interpreted by cardiac progenitors and cardiomyocytes, which then engage intracellular cascades that ultimately influence cell-cycle entry. The balance of these inputs determines whether the heart grows appropriately or becomes hypoplastic or hyperplastic.
Intracellular signal integration
In simple terms: Inside the cell, several pathways talk to each other to decide whether to divide.
Once receptors are activated, intracellular pathways integrate the signals. Notch and TGF-beta signaling are prominent in cardiac fibroblasts and can suppress or modify proliferative responses during remodeling and development. Rnd3 activation in fibroblasts protects against cardiac remodeling by suppressing Notch and TGF-beta signaling, illustrating how intracellular regulators can dampen proliferative and fibrotic programs. These pathways intersect with cell-cycle machinery, and their output is context-dependent: the same signal can promote proliferation in one cell type and inhibit it in another.
Cell-cycle entry and progression
In simple terms: The final step is the cell actually committing to divide and progressing through the cell cycle.
After signal integration, cardiac cells enter and progress through the cell cycle. In zebrafish, heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation, showing that adult cardiomyocytes can re-enter the cell cycle when appropriate regulatory inputs are present. This step is controlled by cyclins, cyclin-dependent kinases and their inhibitors, although the specific regulators vary by species and cell type. The GO term captures the modulation of this step specifically in the context of heart morphogenesis, meaning the proliferative output must be coordinated with chamber formation and tissue architecture.
Coordination with morphogenesis
In simple terms: Proliferation must be coordinated with the heart taking shape.
Proliferation during heart morphogenesis is not an isolated event; it is coordinated with cell migration, differentiation and tissue folding. Epithelial-to-mesenchymal transition is a key morphogenetic process in developmental remodeling, and it can influence proliferative behavior in cardiac tissues. Cardiac fibroblasts contribute to the structural and signaling environment that shapes morphogenesis, and their proliferative state is regulated by pathways such as Notch and TGF-beta. This coordination ensures that the heart achieves the correct size and shape while maintaining functional integrity.
Resolution and exit from proliferation
In simple terms: At some point, the cells stop dividing so the heart can mature.
As heart morphogenesis progresses, proliferative programs are downregulated and cells exit the cell cycle. In the adult heart, most cardiomyocytes are post-mitotic, but they can be induced to proliferate under regenerative conditions, as shown in zebrafish. Fibroblasts, by contrast, can remain responsive to proliferative and fibrotic signals, and their regulation involves Notch and TGF-beta pathways. The resolution phase is therefore an active regulatory step, and failure to properly exit proliferation can contribute to pathological remodeling.
Key Genes Involved in GO:2000136 regulation of cell proliferation involved in heart morphogenesis
The following genes and proteins are recurrently implicated in the regulation of cell proliferation during heart morphogenesis and related cardiac contexts.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EGFR | EGF receptor signaling in organ development and tissue homeostasis | Regulates proliferative expansion in developing tissues; target for KO and overexpression studies |
| FGF | FGF-dependent metabolic control of vascular development | Links metabolism to proliferation in cardiac vasculature; suitable for knock-in and point-mutation models |
| NOTCH | Suppresses or modifies proliferative responses in cardiac fibroblasts | Key node in remodeling; target for pathway perturbation |
| TGFB1 | TGF-beta signaling in cardiac fibroblasts | Drives fibrotic and proliferative programs; relevant to remodeling models |
| RND3 | Suppresses Notch and TGF-beta signaling in fibroblasts | Protective in cardiac remodeling; candidate for overexpression and KO |
| PDPN | Podoplanin in inflammation and cancer | Marker of fibroblast and inflammatory states; useful for lineage tracing |
| CDH1 | Epithelial-to-mesenchymal transition in developmental morphogenesis | Morphogenetic regulator; relevant to cardiac EMT-like processes |
| SSNA1 | Centriole maintenance and microtubule binding | Cell division machinery component; relevant to proliferative capacity |
| MYC | Cell-cycle and growth control (general) | Downstream proliferative effector; candidate for expression profiling |
| CCND1 | G1/S transition (general) | Cell-cycle marker; used in proliferation assays |
| CDKN1A | Cell-cycle inhibitor (general) | Readout of proliferative arrest; relevant to exit from proliferation |
| MKI67 | Proliferation marker (general) | Commonly used to quantify proliferating cells in cardiac tissue |
| GATA4 | Cardiac transcription factor (general) | Developmental regulator; candidate for cardiac morphogenesis studies |
| NKX2-5 | Cardiac transcription factor (general) | Early cardiac development; relevant to morphogenesis |
| TBX5 | Cardiac transcription factor (general) | Chamber formation and development; candidate for functional studies |
| VEGFA | Vascular development (general) | Links vascularization to cardiac growth; relevant to FGF-dependent pathways |
| COL1A1 | Fibroblast matrix production (general) | Readout of fibroblast activation in remodeling |
How Is regulation of cell proliferation involved in heart morphogenesis Regulated?
Regulation of cell proliferation involved in heart morphogenesis is controlled by a layered network of extracellular signals and intracellular feedback. EGF receptor signaling is a central regulator of organ development and tissue homeostasis, and its activity can be modulated by ligand availability and receptor trafficking. FGF signaling couples metabolic state to vascular development, providing a mechanism by which nutrient and oxygen availability influence proliferative decisions in the heart. Notch and TGF-beta pathways act as context-dependent regulators, often suppressing proliferation in fibroblasts and contributing to remodeling when chronically activated. Rnd3 provides an example of an intracellular brake that suppresses Notch and TGF-beta signaling, protecting against cardiac remodeling. In zebrafish, cardiomyocyte dedifferentiation and proliferation are reactivated during regeneration, indicating that the regulatory network is not permanently silenced but can be re-engaged. Together, these mechanisms ensure that proliferation is tuned to the developmental and physiological state of the heart.
regulation of cell proliferation involved in heart morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EGFR | Congenital heart defects and developmental proliferation disorders | Cardiac-specific knockout and overexpression in mouse or zebrafish |
| FGF | Vascular and metabolic contributions to cardiac development | Knock-in of signaling variants and metabolic profiling |
| RND3 | Diabetic cardiomyopathy and cardiac remodeling | Fibroblast-specific overexpression and knockout |
| NOTCH | Cardiac fibrosis and remodeling | Pathway perturbation with KO and point-mutation models |
| PDPN | Inflammation and fibroblast activation | Lineage tracing and knockout in injury models |
Congenital heart defects
Altered regulation of cell proliferation during heart morphogenesis can lead to congenital heart defects, including hypoplastic chambers and septal abnormalities. Because EGF receptor and FGF signaling control proliferative expansion in developing tissues, perturbations in these pathways can disrupt the cell numbers required for normal heart formation. Cardiac fibroblasts also contribute to the structural environment of the developing heart, and their dysregulation can affect morphogenesis. Understanding GO:2000136 helps explain how genetic and environmental insults converge on proliferative control to produce structural heart disease.
Cardiac remodeling and fibrosis
In adult hearts, pathways that regulate developmental proliferation can be reactivated in pathological remodeling. Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy by suppressing Notch and TGF-beta signaling, showing that proliferative and fibrotic programs in fibroblasts are causally linked to disease progression. Cardiac fibroblasts can help or hurt depending on context, and their proliferative state is a key determinant of outcome. This makes GO:2000136 relevant not only to development but also to adult cardiac pathology.
Cardiac regeneration
Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation, demonstrating that the proliferative programs controlled by GO:2000136 can be reactivated in adult hearts. This has motivated efforts to identify the regulatory inputs that permit or restrict cardiomyocyte proliferation in mammals. EGF receptor and FGF signaling are candidate pathways for promoting regenerative proliferation, while Notch and TGF-beta signaling may need to be suppressed. Research on GO:2000136 therefore informs strategies for cardiac repair.
Inflammation and fibroblast activation
Podoplanin is involved in inflammation and cancer and marks fibroblast and inflammatory states that can influence cardiac tissue. Epithelial-to-mesenchymal transition is a developmental morphogenetic process that can be reactivated in disease and affects proliferative behavior. These processes intersect with the regulation of cell proliferation in the heart, particularly in conditions where inflammation and fibrosis accompany cardiac injury.
From regulation of cell proliferation involved in heart morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for cardiomyocyte proliferation during heart morphogenesis? | CRISPR knockout in zebrafish or mouse |
| Does a specific point mutation alter signaling output in cardiac cells? | CRISPR point-mutation knock-in in cardiac cell lines or mouse |
| Can a protective allele rescue remodeling phenotypes? | Knock-in of the variant followed by injury modeling |
| Where and when is a candidate protein expressed during heart development? | Tagged knock-in with fluorescent or epitope tag |
| Does overexpression of a regulator increase proliferative capacity? | Transgenic or viral overexpression in cardiac tissue |
| Which pathways cooperate to control proliferation in fibroblasts? | Combined knockout and pathway inhibition in fibroblast cultures |
How to Study the regulation of cell proliferation involved in heart morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA sequencing | Transcript abundance and pathway enrichment | Identify proliferative gene signatures in developing hearts |
| Single-cell RNA sequencing | Cell-type-specific expression | Resolve which cardiac cell types express regulators |
| EdU/BrdU incorporation | DNA synthesis and cell-cycle entry | Quantify proliferation in cardiac tissue |
| Phospho-histone H3 staining | Mitotic cells | Measure proliferation in situ |
| Confocal/light-sheet imaging | Spatial distribution of proliferating cells | Map proliferation during morphogenesis |
| Phosphoproteomics | Signaling pathway activity | Assess EGF, FGF, Notch and TGF-beta output |
| CRISPR knockout | Gene requirement | Test causality in cardiac development |
| CRISPR knock-in | Variant or reporter function | Dissect signaling residues and expression |
Transcriptomic profiling
RNA sequencing of developing hearts or cardiac cell populations can identify genes whose expression correlates with proliferative states. Comparing wild-type and mutant hearts reveals pathways that are enriched or depleted during morphogenesis, and can highlight EGF receptor, FGF, Notch and TGF-beta targets. Single-cell RNA sequencing further resolves which cell types express these regulators, which is essential because proliferation control is cell-type specific in the heart.
Proliferation assays and imaging
Quantifying proliferating cells is central to studying GO:2000136. EdU or BrdU incorporation, phospho-histone H3 staining and Ki67 immunostaining are commonly used to measure cell-cycle entry in cardiac tissue. Confocal and light-sheet imaging of reporter lines allows spatial mapping of proliferation during heart morphogenesis. These methods are often combined with lineage tracing to determine whether proliferating cells contribute to specific cardiac structures.
Proteomics and signaling analysis
Phosphoproteomics and targeted signaling assays can measure pathway activity downstream of EGF receptor, FGF, Notch and TGF-beta. These approaches reveal which intracellular cascades are engaged in a given model and can identify feedback mechanisms that modulate proliferation. Proteomic profiling of cardiac fibroblasts, for example, can show how Rnd3 activation alters Notch and TGF-beta signaling output.
Functional perturbation with CRISPR
CRISPR-based perturbation is the most direct way to test causality for genes implicated in GO:2000136. Knockout of a candidate gene in zebrafish or mouse can reveal developmental phenotypes, while point mutations can dissect specific signaling residues. Knock-in reporters and overexpression models complement loss-of-function approaches by showing sufficiency and expression dynamics. Together these methods provide a causal framework for understanding how proliferation is regulated during heart morphogenesis.
How CRISPR Can Be Used to Study GO:2000136 regulation of cell proliferation involved in heart morphogenesis
Knockout
CRISPR knockout is used to remove a candidate regulator and determine whether it is required for normal proliferation during heart morphogenesis. For example, knocking out EGF receptor pathway components in zebrafish or mouse can reveal developmental proliferation defects. Knockout of FGF pathway genes can disrupt vascular development and metabolic control in the heart. These models provide loss-of-function evidence that a gene is causally involved in GO:2000136.
Point Mutation
Point-mutation knock-in allows researchers to test specific residues or variants without eliminating the entire protein. This is particularly useful for signaling receptors and intracellular regulators where phosphorylation sites or binding interfaces are known. In cardiac remodeling, point mutations in Notch or TGF-beta pathway components can reveal which signaling arms drive proliferative and fibrotic responses. Such models bridge genotype and phenotype at high resolution.
Knock-in
Knock-in of reporters, tags or human variants enables visualization and functional analysis of genes involved in heart morphogenesis. Tagged knock-in lines can show where a protein is expressed during development and how it localizes in proliferating cells. Knock-in of disease-associated variants can model congenital heart defects or cardiomyopathy in vivo. These approaches are essential for linking GO:2000136 to specific molecular mechanisms.
Overexpression
Overexpression models test sufficiency: does increasing a regulator drive or suppress proliferation in the heart? Transgenic overexpression of regenerative factors can enhance cardiomyocyte proliferation in zebrafish and other models. Fibroblast-specific overexpression of Rnd3 protects against cardiac remodeling by suppressing Notch and TGF-beta signaling, demonstrating that gain-of-function approaches can reveal protective mechanisms. Overexpression is therefore a key complement to knockout studies for GO:2000136.
How EDITGENE Supports regulation of cell proliferation involved in heart morphogenesis Research
Researchers studying regulation of cell proliferation involved in heart morphogenesis-related genes often need to determine whether a candidate gene is causally involved in proliferative control, which signaling residues matter, and how expression dynamics relate to cardiac morphogenesis. EDITGENE provides the CRISPR and screening tools required to answer these questions in cardiac cell models and animal systems.
Contact EDITGENE today to design your custom CRISPR model for regulation of cell proliferation involved in heart morphogenesis research.
Frequently Asked Questions About regulation of cell proliferation involved in heart morphogenesis
What is GO:2000136?
GO:2000136 is the Gene Ontology term for regulation of cell proliferation involved in heart morphogenesis, defined as any process that modulates the frequency, rate or extent of cell proliferation during heart morphogenesis.
What does regulation of cell proliferation involved in heart morphogenesis mean?
It refers to the signals and intracellular mechanisms that control how often cardiac cells divide while the heart is forming, including EGF receptor, FGF, Notch and TGF-beta inputs.
What genes are involved in regulation of cell proliferation involved in heart morphogenesis?
Genes implicated include EGFR, FGF pathway components, NOTCH, TGFB1, RND3, PDPN and morphogenesis-related genes such as CDH1.
Why is cardiomyocyte proliferation important for heart development?
Cardiomyocyte proliferation determines the final number of muscle cells in the heart, and its regulation is essential for normal chamber formation and function.
Can the heart regenerate by cardiomyocyte proliferation?
Yes, zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation, showing that proliferative programs can be reactivated in adult hearts.
How is EGF receptor signaling linked to heart morphogenesis?
EGF receptor signaling is a central regulator of organ development and tissue homeostasis and can influence proliferative expansion in developing tissues, including the heart.
What role does FGF signaling play in cardiac development?
FGF signaling provides metabolic control of vascular development, linking nutrient and oxygen status to proliferative and vascular growth in the forming heart.
How do Notch and TGF-beta signaling affect cardiac fibroblasts?
Notch and TGF-beta signaling regulate fibroblast proliferation and activation, and their suppression by Rnd3 protects against cardiac remodeling.
What experimental models are used to study GO:2000136?
Zebrafish, mouse and cardiac cell culture are commonly used, with CRISPR knockout, knock-in, overexpression and proliferation assays.
How can CRISPR help study heart morphogenesis genes?
CRISPR enables knockout, point-mutation, knock-in and overexpression models to test whether a gene is required or sufficient for proliferative control during heart morphogenesis.
Conclusion
GO:2000136, regulation of cell proliferation involved in heart morphogenesis, defines the regulatory layer that controls how many cells are produced as the heart forms. It integrates extracellular signals such as EGF receptor and FGF with intracellular pathways including Notch and TGF-beta, and it is conserved across vertebrates. The term is important for understanding congenital heart defects, cardiac remodeling and regeneration, and it provides a framework for interpreting proliferative phenotypes in cardiac models. CRISPR-based knockout, point-mutation, knock-in and overexpression approaches, combined with transcriptomic and imaging methods, offer a rigorous path to causal discovery. Researchers can leverage these tools to identify new regulators and therapeutic targets within this process.
References
- 1. Tito C et al.. 2025. EGF receptor in organ development, tissue homeostasis and regeneration.. J Biomed Sci 32(1):24 PMID: 39966897
- 2. Jopling C et al.. 2010. Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation.. Nature 464(7288):606-9 PMID: 20336145
- 3. Yu P et al.. 2017. FGF-dependent metabolic control of vascular development.. Nature 545(7653):224-228 PMID: 28467822
- 4. Quintanilla M et al.. 2019. Podoplanin in Inflammation and Cancer.. Int J Mol Sci 20(3) PMID: 30736372
- 5. Nakaya Y et al.. 2013. EMT in developmental morphogenesis.. Cancer Lett 341(1):9-15 PMID: 23462225
- 6. Agostini L et al.. 2025. Structural insights into SSNA1 self-assembly and its microtubule binding for centriole maintenance.. Nat Commun 16(1):7512 PMID: 40804232
- 7. Shameem M et al.. 2025. Cardiac Fibroblasts: Helping or Hurting.. Genes (Basel) 16(4) PMID: 40282342
- 8. Zhang Y et al.. 2022. Fibroblast-specific activation of Rnd3 protects against cardiac remodeling in diabetic cardiomyopathy via suppression of Notch and TGF-β signaling.. Theranostics 12(17):7250-7266 PMID: 36438502
